These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25646943)

  • 21. Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adults.
    Minze MG; Klein MS; Terrell BT
    Clin Med Insights Endocrinol Diabetes; 2013; 6():15-24. PubMed ID: 23966808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of saxagliptin added to sub-maximal doses of metformin compared with uptitration of metformin in type 2 diabetes: the PROMPT study.
    Hermans MP; Delibasi T; Farmer I; Lohm L; Maheux P; Piatti P; Malvolti E; Jörgens S; Charbonnel B
    Curr Med Res Opin; 2012 Oct; 28(10):1635-45. PubMed ID: 23020253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Place in therapy for liraglutide and saxagliptin for type 2 diabetes.
    McFarland MS; Brock M; Ryals C
    South Med J; 2011 Jun; 104(6):426-39. PubMed ID: 21886033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes.
    Katzeff HL; Williams-Herman D; Xu L; Golm GT; Wang H; Dong Q; Johnson JR; O'Neill EA; Kaufman KD; Engel SS; Goldstein BJ
    Curr Med Res Opin; 2015 Jun; 31(6):1071-7. PubMed ID: 25850968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Kay S; Strickson A; Puelles J; Selby R; Benson E; Tolley K
    Diabetes Ther; 2017 Apr; 8(2):251-273. PubMed ID: 28275958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saxagliptin plus metformin combination therapy.
    Scheen AJ
    Expert Rev Endocrinol Metab; 2012 Mar; 7(2):151-164. PubMed ID: 30764006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments.
    Mooradian AD
    Treat Endocrinol; 2004; 3(5):279-87. PubMed ID: 15330676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Saxagliptin versus glipizide as add-on therapy to metformin: assessment of hypoglycemia.
    Mintz ML; Minervini G
    Curr Med Res Opin; 2014 May; 30(5):761-70. PubMed ID: 24397584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Canagliflozin as Add-On Therapy to Metformin in Type 2 Diabetes.
    Battise DM
    Clin Diabetes; 2014 Apr; 32(2):81-6. PubMed ID: 26130867
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on Safety Issues Related to Antihyperglycemic Therapy.
    Carpio GR; Fonseca VA
    Diabetes Spectr; 2014 May; 27(2):92-100. PubMed ID: 26246765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes, not clinical utility, should be the major consideration for saxagliptin with or without metformin.
    Doggrell SA
    Patient Prefer Adherence; 2014; 8():473-5. PubMed ID: 24790414
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of treatment with saxagliptin on glycaemic stability and β-cell function in the SAVOR-TIMI 53 study.
    Leibowitz G; Cahn A; Bhatt DL; Hirshberg B; Mosenzon O; Wei C; Jermendy G; Sheu WH; Sendon JL; Im K; Braunwald E; Scirica BM; Raz I
    Diabetes Obes Metab; 2015 May; 17(5):487-94. PubMed ID: 25656169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients.
    Esposito K; Chiodini P; Maiorino MI; Capuano A; Cozzolino D; Petrizzo M; Bellastella G; Giugliano D
    BMJ Open; 2015 Feb; 5(2):e005892. PubMed ID: 25687897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
    Leiter LA; Teoh H; Braunwald E; Mosenzon O; Cahn A; Kumar KM; Smahelova A; Hirshberg B; Stahre C; Frederich R; Bonnici F; Scirica BM; Bhatt DL; Raz I;
    Diabetes Care; 2015 Jun; 38(6):1145-53. PubMed ID: 25758769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noncardiac Pulmonary Edema induced by Sitagliptin Treatment.
    Belice T; Yuce S; Kizilkaya B; Kurt A; Cure E
    J Family Med Prim Care; 2014; 3(4):456-7. PubMed ID: 25657966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
    Koska J; Sands M; Burciu C; Reaven P
    Diab Vasc Dis Res; 2015 May; 12(3):154-63. PubMed ID: 25852133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis.
    Jia Y; Lao Y; Leung SW
    BMJ Open; 2015 Mar; 5(3):e006139. PubMed ID: 25762228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION).
    Schernthaner G; Durán-Garcia S; Hanefeld M; Langslet G; Niskanen L; Östgren CJ; Malvolti E; Hardy E
    Diabetes Obes Metab; 2015 Jul; 17(7):630-8. PubMed ID: 25761977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin.
    Wang MM; Lin S; Chen YM; Shu J; Lu HY; Zhang YJ; Xie RY; Zeng LY; Mu PW
    Diabetes Res Clin Pract; 2015 Jun; 108(3):e67-70. PubMed ID: 25841300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.